相关实验视频
Updated: Jun 27, 2026

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.3K
在患有大缺血性心脏病发作的患者中,血栓切除术的再输血依赖治疗效应
Lukas Meyer1, Susanne Gellißen1, Götz Thomalla2
1Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
概括
大型中风的内血管血栓切除术 (EVT) 如果再注血不成功,结果不会恶化. 通过EVT实现完整的第一通再输,显著改善了中风患者的治疗结果,并降低了中风患者的死亡率.
科学领域:
- 神经学 神经学
- 干预心脏病学 干预心脏病学
- 脑卒中医学 脑卒中医学
背景情况:
- 血管内血栓切除术 (EVT) 对大型心脏病发作有好处,但其在不同反水平的有效性尚不清楚.
- 这项研究研究了再输血成功对EVT结果对患有广泛中风的患者的影响.
研究的目的:
- 研究重灌程度如何影响EVT加最佳医疗治疗 (BMT) 与仅仅BMT在大型中风患者中的有效性.
- 根据再输血水平,比较功能结果,心脏病发作量,死亡率和出血率.
主要方法:
- 对TENSION试验 (随机对照研究) 的后期分析,比较EVT和BMT在患有广泛性心脏病发作的患者中 (阿尔伯塔中风计划早期CT分数[方面] 3-5).
- 主要结局:90天后修改的兰金度量表 (mRS). 二次结局:心脏病发作量,死亡率,症状出血.
- 结果按最终转流水平分层 (大脑梗塞中修改型血栓溶解[mTICI]尺度);使用反向概率加权的混调整分析.
主要成果:
- 不成功的EVT (mTICI ≤ 2a) 与单独的BMT相比,与更差的功能结果,死亡率或心脏病发作量无关.
- 第一通完全再输血 (mTICI 3) 显示了最大的益处,显著改善了mRS得分 (常见概率 [cOR]:4.85) 并将死亡率降低了29%.
结论:
- 在大型中风患者中,不成功的EVT并没有导致比单独的BMT更糟糕的结果.
- 在这个患者群体中,实现完整的第一通再输是最大限度地提高EVT效益的关键.
- 目前的发现不支持仅基于再输血水平的EVT的一般治疗建议.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

